Systemic and network functions of the microtubule-associated protein tau: Implications for tau-based therapies

被引:19
作者
Bakota, Lidia [1 ]
Ussif, Abdala [1 ]
Jeserich, Gunnar [1 ]
Brandt, Roland [1 ]
机构
[1] Univ Osnabruck, Dept Neurobiol, Barbarastr 11, D-49076 Osnabruck, Germany
关键词
Alzheimer's disease; Tau; Microtubule-associated protein; Tauopathy; Neuronal network; INTRINSICALLY DISORDERED PROTEINS; HUMAN WILD-TYPE; AMYLOID-BETA; DENDRITIC SIMPLIFICATION; NEURONAL PLASTICITY; ENDOGENOUS TAU; SPINE LOSS; A-BETA; MICE; PHOSPHORYLATION;
D O I
10.1016/j.mcn.2017.03.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tau is a microtubule-associated neuronal protein, whose primary role was long thought to regulate axonal microtubule assembly. Tau is subject to many posttranslational modifications and can aggregate into neurofibrillary tangles, which are considered to be a hallmark of several neurodegenerative diseases collectively called "tauopathies". The most common tauopathy is Alzheimer's disease, where tau pathology correlates with sites of neurodegeneration. Tau belongs to the class of intrinsically disordered proteins, which are known to interact with many partners and are considered to be involved in various signaling, regulation and recognition processes. Thus more recent evidence indicates that tau functionally interacts with many proteins and different cellular structures, which may have an important physiological role and may be involved in neurodegenerative processes. Furthermore, tau can be released from neurons and exert functional effects on other cells. This review article weighs the evidence that tau has subtle but important systemic effects on neuronal network function by maintaining physiological neuronal transmission and synaptic plasticity, which are possibly independent from tau's microtubule modulating activities. Implications for tau-based therapeutic approaches are discussed. (C) 2017 Elsevier Inc. All rights reserved.
引用
收藏
页码:132 / 141
页数:10
相关论文
共 104 条
[1]   Genetic Ablation of Tau Mitigates Cognitive Impairment Induced by Type 1 Diabetes [J].
Abbondante, Serena ;
Baglietto-Vargas, David ;
Rodriguez-Ortiz, Carlos J. ;
Estrada-Hernandez, Tatiana ;
Medeiros, Rodrigo ;
LaFerla, Frank M. .
AMERICAN JOURNAL OF PATHOLOGY, 2014, 184 (03) :819-826
[2]   Cognition and hippocampal synaptic plasticity in mice with a homozygous tau deletion [J].
Ahmed, Tariq ;
Van der Jeugd, Ann ;
Blum, David ;
Galas, Marie-Christine ;
D'Hooge, Rudi ;
Buee, Luc ;
Balschun, Detlef .
NEUROBIOLOGY OF AGING, 2014, 35 (11) :2474-2478
[3]   Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms [J].
Andorfer, C ;
Kress, Y ;
Espinoza, M ;
de Silva, R ;
Tucker, KL ;
Barde, YA ;
Duff, K ;
Davies, P .
JOURNAL OF NEUROCHEMISTRY, 2003, 86 (03) :582-590
[4]   STRUCTURE AND NOVEL EXONS OF THE HUMAN-TAU GENE [J].
ANDREADIS, A ;
BROWN, WM ;
KOSIK, KS .
BIOCHEMISTRY, 1992, 31 (43) :10626-10633
[5]  
[Anonymous], 2013, ABSTR APPL AN
[6]   Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals [J].
Arendt, T ;
Stieler, J ;
Strijkstra, AM ;
Hut, RA ;
Rüdiger, J ;
Van der Zee, EA ;
Harkany, T ;
Holzer, M ;
Härtig, W .
JOURNAL OF NEUROSCIENCE, 2003, 23 (18) :6972-6981
[7]   Tau and tauopathies [J].
Arendt, Thomas ;
Stieler, Jens T. ;
Holzer, Max .
BRAIN RESEARCH BULLETIN, 2016, 126 :238-292
[8]   Intrinsically disordered proteins: regulation and disease [J].
Babu, M. Madan ;
van der Lee, Robin ;
de Groot, Natalia Sanchez ;
Gsponer, Joerg .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2011, 21 (03) :432-440
[9]   Tau Biology and Tau-Directed Therapies for Alzheimer's Disease [J].
Bakota, Lidia ;
Brandt, Roland .
DRUGS, 2016, 76 (03) :301-313
[10]  
Blennow K, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fnins.7015.00345, 10.3389/fnins.2015.00345]